Business Services Industry
Mylan Speaks To Zagam
Business Wire, Feb 16, 2001
Business Editors
PITTSBURGH--(BUSINESS WIRE)--Feb. 16, 2001
Mylan Laboratories Inc. (NYSE:MYL) has indicated that they are presently marketing the antibiotic, Zagam(R), and it remains a part of their Bertek branded product line.
Mylan wrote down $3.6 million of the Zagam(R) product license asset in their third quarter, which was reported on January 30, 2001, because of supply issues.
Mylan continues to work to try and resolve the issues surrounding Zagam(R).
Mylan Laboratories Inc., is one of the largest manufacturers and marketers of prescription generic pharmaceuticals in the United States. Mylan also develops and markets branded pharmaceutical products through its Bertek Pharmaceuticals Inc. subsidiary.
Most Recent Business Articles
- How do I determine my retainer fee?
- Why fly solo when an executive assistant can accelerate your CLNC® business?
- The CLNC® mentors held the key to my first case and to my CLNC® success
- Atlanta CLNC® 6-day certification seminar photo gallery—plus sign up today for spring 2009 to save $100.00
- Speak to a full-time practicing CLNC® consultant
Most Recent Business Publications
Most Popular Business Articles
- Using object-oriented analysis and design over traditional structured analysis and design
- Big Fish Games Migrates Upstream to Fisher Plaza; High Growth Online Gaming Firm Vaults Fisher Plaza Occupancy Rate Above 90%
- Top of the line: some of the world's most well-respected doctors practice in South Florida. A guide to choosing the best physician specialists - Top Doctors in South Florida
- Sand filter basics: high-rate sand filters can be confusing for those new to the business. Understanding valve modes is the key
- BEHR Paints Introduces a Colorful New Way to Paint and Prime All in One with BEHR Premium Plus Ultra™ Interior
Most Popular Business Publications
Content provided in partnership with http://findarticles.com/source//
Sponsored by Merrill Lynch